SEGALL BRYANT & HAMILL, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2022$1,230,000
-17.2%
152,014
+42.0%
0.01%0.0%
Q1 2022$1,485,000
-50.4%
107,041
+0.3%
0.01%
-50.0%
Q4 2021$2,996,000
-56.7%
106,774
-47.6%
0.03%
-15.2%
Q3 2021$6,920,000
+70.9%
203,608
+105.5%
0.03%
-15.4%
Q2 2021$4,048,000
+8.0%
99,096
+6.4%
0.04%
+5.4%
Q1 2021$3,748,000
-33.1%
93,094
-1.7%
0.04%
-40.3%
Q4 2020$5,599,000
+19.4%
94,680
-1.8%
0.06%
-3.1%
Q3 2020$4,690,000
+267.0%
96,462
+265.0%
0.06%
+204.8%
Q2 2020$1,278,000
+229.4%
26,425
+89.4%
0.02%
+162.5%
Q1 2020$388,00013,9500.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders